Henry Schein Return on Tangible Equity 2010-2023 | HSIC

Current and historical return on tangible equity values for Henry Schein (HSIC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Henry Schein Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.42B $-0.50B 904.35%
2023-09-30 $0.45B $-0.15B 136.82%
2023-06-30 $0.46B $0.17B 83.65%
2023-03-31 $0.48B $0.66B 68.09%
2022-12-31 $0.54B $0.62B 75.01%
2022-09-30 $0.64B $0.74B 91.31%
2022-06-30 $0.65B $0.79B 95.03%
2022-03-31 $0.65B $0.72B 98.48%
2021-12-31 $0.63B $0.54B 93.03%
2021-09-30 $0.63B $0.68B 79.04%
2021-06-30 $0.61B $0.68B 73.91%
2021-03-31 $0.44B $0.81B 54.51%
2020-12-31 $0.40B $1.00B 53.92%
2020-09-30 $0.59B $0.79B 91.24%
2020-06-30 $0.59B $0.62B 106.64%
2020-03-31 $0.72B $0.58B 145.09%
2019-12-31 $0.70B $0.60B 160.00%
2019-09-30 $0.50B $0.42B 89.51%
2019-06-30 $0.48B $0.38B 99.38%
2019-03-31 $0.51B $0.35B 126.41%
2018-12-31 $0.54B $1.09B 178.78%
2018-09-30 $0.39B $0.11B -4491.43%
2018-06-30 $0.41B $0.05B -8631.58%
2018-03-31 $0.41B $-0.06B 3115.38%
2017-12-31 $0.41B $-0.15B 662.86%
2017-09-30 $0.55B $0.13B 401.45%
2017-06-30 $0.55B $0.13B 290.62%
2017-03-31 $0.53B $0.14B 205.58%
2016-12-31 $0.51B $0.16B 157.33%
2016-09-30 $0.50B $0.33B 131.49%
2016-06-30 $0.49B $0.41B 122.54%
2016-03-31 $0.49B $0.39B 123.12%
2015-12-31 $0.48B $0.39B 129.20%
2015-09-30 $0.48B $0.43B 139.11%
2015-06-30 $0.47B $0.39B 151.05%
2015-03-31 $0.47B $0.28B 146.39%
2014-12-31 $0.47B $0.29B 130.72%
2014-09-30 $0.46B $0.28B 97.60%
2014-06-30 $0.45B $0.43B 80.29%
2014-03-31 $0.44B $0.43B 73.99%
2013-12-31 $0.43B $0.74B 69.64%
2013-09-30 $0.42B $0.65B 73.11%
2013-06-30 $0.41B $0.57B 75.84%
2013-03-31 $0.40B $0.52B 75.09%
2012-12-31 $0.39B $0.55B 69.29%
2012-09-30 $0.38B $0.51B 68.83%
2012-06-30 $0.38B $0.54B 64.74%
2012-03-31 $0.37B $0.64B 62.10%
2011-12-31 $0.37B $0.53B 65.22%
2011-09-30 $0.36B $0.62B 61.55%
2011-06-30 $0.35B $0.62B 63.33%
2011-03-31 $0.34B $0.49B 65.14%
2010-12-31 $0.33B $0.58B 59.63%
2010-09-30 $0.32B $0.53B 49.55%
2010-06-30 $0.33B $0.49B 44.63%
2010-03-31 $0.32B $0.58B 36.58%
2009-12-31 $0.31B $0.97B 32.71%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.104B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00